{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T12:43:24Z","timestamp":1789044204134,"version":"build-2803163510"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,9,8]],"date-time":"2022-09-08T00:00:00Z","timestamp":1662595200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,9,8]],"date-time":"2022-09-08T00:00:00Z","timestamp":1662595200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003009","name":"Science and Technology Development Fund","doi-asserted-by":"publisher","award":["34823"],"award-info":[{"award-number":["34823"]}],"id":[{"id":"10.13039\/501100003009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Egypt Heart J"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Childhood dilated cardiomyopathy (CDCM) is the most common cardiomyopathy in children and it is risk factor to heart failure and sudden death. Most of the different etiologic factors which have been postulated to DCM are idiopathic, and its pathogenesis remains uncertain. So it was worth investigating the potential DCM pathogenicity models to establish early noninvasive diagnosis parameters especially in CDCM patients. Beside that miRNAs in the circulatory blood are genetically considered the best option for noninvasive diagnosis; also, implementation of miRNAs as early diagnostic markers for children with DCM is urgent because those children have high risk to sudden heart death. We aimed to identify discriminator diagnostic circulatory miRNA expression levels in CDCM patients.\n<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The expression levels of miR-454-3p and miR-194-5p were found significant upregulated (<jats:italic>p<\/jats:italic> value\u2009=\u20090.001 and 0.018; CI 95%, respectively), while miR-875-3p was found significant downregulated (<jats:italic>p<\/jats:italic> value\u2009=\u20090.040; CI 95%). A receiver operating characteristic (ROC) curve analysis showed significant AUC\u2009=\u20091.000 and 0.798 for miR-454-3p and miR-194-5p, respectively, and the optimal discriminated diagnostic cut-points were computed by index of union (IU) method. Enrichment analysis for the potential targeted mature mRNAs by miR-454-3p and miR-194-5p pointed that Ca, Na and K ions homeostasis in cardiac sarcolemma consider potential CDCM pathogenicity model.\n<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>miR-454-3p and miR-194-5p are highly influencing noninvasive biomarkers for CDCM, and further circulatory miRNAs-implicated studies are highly recommended.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s43044-022-00300-x","type":"journal-article","created":{"date-parts":[[2022,9,8]],"date-time":"2022-09-08T21:05:33Z","timestamp":1662671133000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["miR-454-3p and miR-194-5p targeting cardiac sarcolemma ion exchange transcripts are potential noninvasive diagnostic biomarkers for childhood dilated cardiomyopathy in Egyptian patients"],"prefix":"10.1186","volume":"74","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3433-3033","authenticated-orcid":false,"given":"Alaaeldin G.","family":"Fayez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nora N.","family":"Esmaiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sohair M.","family":"Salem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Engy A.","family":"Ashaat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia A.","family":"El-Saiedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona O.","family":"El Ruby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,8]]},"reference":[{"key":"300_CR1","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1093\/eurheartj\/ehm342","volume":"29","author":"P Elliott","year":"2007","unstructured":"Elliott P, Andersson B, Arbustini E, Bilinska Z, Cecchi F, Charron P et al (2007) Classification of the cardiomyopathies: a position statement from the European society of cardiology working group on myocardial and pericardial diseases. Eur Heart J 29:270\u2013276","journal-title":"Eur Heart J"},{"key":"300_CR2","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1093\/eurheartj\/ehv727","volume":"37","author":"YM Pinto","year":"2016","unstructured":"Pinto YM, Elliott PM, Arbustini E, Adler Y, Anastasakis A, B\u00f6hm M et al (2016) Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for clinical practice: a position statement of the ESC working group on myocardial and pericardial diseases. Eur Heart J 37:1850\u20131858","journal-title":"Eur Heart J"},{"key":"300_CR3","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.accreview.2005.10.037","volume":"14","author":"NG Mahon","year":"2005","unstructured":"Mahon NG, Murphy RT, MacRae CA (2005) Echocardiographic evaluation in asymptomatic relatives of patients with dilated cardiomyopathy reveals preclinical disease. ACC Curr J Rev 14:31","journal-title":"ACC Curr J Rev"},{"key":"300_CR4","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.hfc.2010.05.002","volume":"6","author":"JD Wilkinson","year":"2010","unstructured":"Wilkinson JD, Landy DC, Colan SD, Towbin JA, Sleeper LA, Orav EJ et al (2010) The pediatric cardiomyopathy registry and heart failure: key results from the first 15 years. Heart Fail Clin 6:401\u2013413","journal-title":"Heart Fail Clin"},{"key":"300_CR5","doi-asserted-by":"publisher","first-page":"e233","DOI":"10.1016\/j.carpath.2009.12.002","volume":"19","author":"Y Zhang","year":"2010","unstructured":"Zhang Y, Kanter EM, Yamada KA (2010) Remodeling of cardiac fibroblasts following myocardial infarction results in increased gap junction intercellular communication. Cardiovasc Pathol 19:e233-240","journal-title":"Cardiovasc Pathol"},{"key":"300_CR6","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1161\/CIRCULATIONAHA.110.012237","volume":"124","author":"S Li","year":"2011","unstructured":"Li S, Zhu J, Zhang W, Chen Y, Zhang K, Popescu LM et al (2011) Signature microRNA expression profile of essential hypertension and its novel link to human cytomegalovirus infection. Circulation 124:175\u2013184","journal-title":"Circulation"},{"key":"300_CR7","doi-asserted-by":"publisher","first-page":"S154","DOI":"10.1016\/j.yjmcc.2007.03.499","volume":"42","author":"T Thum","year":"2007","unstructured":"Thum T, Galuppo P, Kneitz S, Fiedler J, Van Laake L, Mummery C et al (2007) MicroRNAs in the human heart: a clue to fetal gene reprogramming in heart failure. J Mol Cell Cardiol 42:S154","journal-title":"J Mol Cell Cardiol"},{"key":"300_CR8","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1373\/clinchem.2010.144121","volume":"56","author":"T Adachi","year":"2010","unstructured":"Adachi T, Nakanishi M, Otsuka Y, Nishimura K, Hirokawa G, Goto Y et al (2010) Plasma microrna 499 as a biomarker of acute myocardial infarction. Clin Chem 56:1183\u20131185","journal-title":"Clin Chem"},{"key":"300_CR9","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1093\/eurjhf\/hfr155","volume":"14","author":"Y Goren","year":"2012","unstructured":"Goren Y, Kushnir M, Zafrir B, Tabak S, Lewis BS, Amir O (2012) Serum levels of microRNAs in patients with heart failure. Eur J Heart Fail 14:147\u2013154","journal-title":"Eur J Heart Fail"},{"key":"300_CR10","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1093\/eurjhf\/hfr179","volume":"14","author":"AG Seto","year":"2012","unstructured":"Seto AG, van Rooij E (2012) Circulating microRNAs to identify human heart failure. Eur J Heart Fail 14:118\u2013119","journal-title":"Eur J Heart Fail"},{"key":"300_CR11","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/nrg3162","volume":"13","author":"AE Pasquinelli","year":"2012","unstructured":"Pasquinelli AE (2012) MicroRNAs and their targets: recognition, regulation and an emerging reciprocal relationship. Nat Rev Genet 13:271\u2013282","journal-title":"Nat Rev Genet"},{"key":"300_CR12","doi-asserted-by":"publisher","first-page":"30","DOI":"10.5339\/gcsp.2014.30","volume":"2014","author":"G Kalozoumi","year":"2014","unstructured":"Kalozoumi G, Yacoub M, Sanoudou D (2014) MicroRNAs in heart failure: small molecules with major impact. Global Cardiol Sci Pract 2014:30","journal-title":"Global Cardiol Sci Pract"},{"key":"300_CR13","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1039\/C4MB00265B","volume":"11","author":"R Isserlin","year":"2015","unstructured":"Isserlin R, Merico D, Wang D, Vuckovic D, Bousette N, Gramolini AO et al (2015) Systems analysis reveals down-regulation of a network of pro-survival miRNAs drives the apoptotic response in dilated cardiomyopathy. Mol Biosyst 11:239\u2013251","journal-title":"Mol Biosyst"},{"key":"300_CR14","doi-asserted-by":"publisher","first-page":"161","DOI":"10.3892\/mmr.2014.2205","volume":"10","author":"H-F Xu","year":"2014","unstructured":"Xu H-F, Ding Y-J, Zhang Z-X, Wang Z-F, Luo C-L, Li B-X et al (2014) MicroRNA-21 regulation of the progression of viral myocarditis to dilated cardiomyopathy. Mol Med Rep 10:161\u2013168","journal-title":"Mol Med Rep"},{"key":"300_CR15","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1172\/JCI62862","volume":"123","author":"EM McNally","year":"2013","unstructured":"McNally EM, Golbus JR, Puckelwartz MJ (2013) Genetic mutations and mechanisms in dilated cardiomyopathy. J Clin Invest 123:19\u201326","journal-title":"J Clin Invest"},{"key":"300_CR16","doi-asserted-by":"publisher","first-page":"e30997","DOI":"10.1371\/journal.pone.0030997","volume":"7","author":"NHH Heegaard","year":"2012","unstructured":"Heegaard NHH, West-N\u00f8rager M, Tanassi JT, Houen G, Nedergaard L, H\u00f8gdall C et al (2012) Circulating antinuclear antibodies in patients with pelvic masses are associated with malignancy and decreased survival. PLoS ONE 7:e30997","journal-title":"PLoS ONE"},{"key":"300_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1755-8794-7-53","volume":"7","author":"RA Rawlings-Goss","year":"2014","unstructured":"Rawlings-Goss RA, Campbell MC, Tishkoff SA (2014) Global population-specific variation in miRNA associated with cancer risk and clinical biomarkers. BMC Med Genomics 7:1\u20133","journal-title":"BMC Med Genomics"},{"key":"300_CR18","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1126\/science.366.6461.22","volume":"366","author":"SE McGeary","year":"2019","unstructured":"McGeary SE, Lin KS, Shi CY, Pham TM, Bisaria N, Kelley GM et al (2019) The biochemical basis of microRNA targeting efficacy. Sci 366:22\u201324","journal-title":"Sci"},{"issue":"D1","key":"300_CR19","doi-asserted-by":"publisher","first-page":"D127","DOI":"10.1093\/nar\/gkz757","volume":"48","author":"Y Chen","year":"2020","unstructured":"Chen Y, Wang X (2020) miRDB: an online database for prediction of functional microRNA targets. Nucleic Acids Res 48(D1):D127\u2013D131","journal-title":"Nucleic Acids Res"},{"key":"300_CR20","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkz896\/5606625","author":"H-Y Huang","year":"2019","unstructured":"Huang H-Y, Lin Y-C-D, Li J, Huang K-Y, Shrestha S, Hong H-C et al (2019) miRTarBase 2020: updates to the experimentally validated microRNA\u2013target interaction database. Nucleic Acids Res. https:\/\/doi.org\/10.1093\/nar\/gkz896\/5606625","journal-title":"Nucleic Acids Res"},{"key":"300_CR21","doi-asserted-by":"publisher","first-page":"e0206239","DOI":"10.1371\/journal.pone.0206239","volume":"13","author":"C Sticht","year":"2018","unstructured":"Sticht C, De La Torre C, Parveen A, Gretz N (2018) miRWalk: an online resource for prediction of microRNA binding sites. PLoS ONE 13:e0206239","journal-title":"PLoS ONE"},{"issue":"D1","key":"300_CR22","doi-asserted-by":"publisher","first-page":"D545","DOI":"10.1093\/nar\/gkaa970","volume":"49","author":"M Kanehisa","year":"2020","unstructured":"Kanehisa M, Furumichi M, Sato Y, Ishiguro-Watanabe M, Tanabe M (2020) KEGG: integrating viruses and cellular organisms. Nucleic Acids Res 49(D1):D545-551","journal-title":"Nucleic Acids Res"},{"key":"300_CR23","doi-asserted-by":"publisher","first-page":"D412","DOI":"10.1093\/nar\/gkn760","volume":"37","author":"LJ Jensen","year":"2009","unstructured":"Jensen LJ, Kuhn M, Stark M, Chaffron S, Creevey C, Muller J et al (2009) STRING 8\u2013a global view on proteins and their functional interactions in 630 organisms. Nucleic Acids Res 37:D412-416","journal-title":"Nucleic Acids Res"},{"key":"300_CR24","unstructured":"https:\/\/www.ibm.com\/products\/spss-statistics. Accessed from 15 Jan 2022"},{"key":"300_CR25","doi-asserted-by":"publisher","first-page":"56","DOI":"10.3109\/1354750X.2015.1118533","volume":"21","author":"EM Co\u015fkun","year":"2015","unstructured":"Co\u015fkun EM, Kervanc\u0131o\u011flu M, \u00d6ztuzcu S, Y\u0131lmaz Co\u015fkun F, Erg\u00fcn S, Ba\u015fp\u0131nar O et al (2015) Plasma microRNA profiling of children with idiopathic dilated cardiomyopathy. Biomark 21:56\u201361","journal-title":"Biomark"},{"issue":"12","key":"300_CR26","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.1017\/S1047951120003157","volume":"30","author":"RK Darwish","year":"2020","unstructured":"Darwish RK, Haghighi A, Seliem ZS, El-Saiedi SA, Radwan NH, El-Gayar DF et al (2020) Genetic study of pediatric hypertrophic cardiomyopathy in Egypt. Cardiol Young 30(12):1910\u20131916","journal-title":"Cardiol Young"},{"issue":"2","key":"300_CR27","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1017\/S1047951121002055","volume":"32","author":"DA Mehaney","year":"2021","unstructured":"Mehaney DA, Haghighi A, Embaby AK, Zeyada RA, Darwish RK, Elfeel NS et al (2021) Molecular analysis of dilated and left ventricular noncompaction cardiomyopathies in Egyptian children. Cardiol Young 32(2):295\u2013300","journal-title":"Cardiol Young"},{"key":"300_CR28","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1038\/nature09783","volume":"469","author":"EM Small","year":"2011","unstructured":"Small EM, Olson EN (2011) Pervasive roles of microRNAs in cardiovascular biology. Nat 469:336\u2013342","journal-title":"Nat"},{"key":"300_CR29","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1152\/physrev.00041.2015","volume":"96","author":"J Beermann","year":"2016","unstructured":"Beermann J, Piccoli M-T, Viereck J, Thum T (2016) Non-coding RNAs in development and disease: background, mechanisms, and therapeutic approaches. Physiol Rev 96:1297\u20131325","journal-title":"Physiol Rev"},{"key":"300_CR30","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.yjmcc.2008.04.014","volume":"45","author":"C Sucharov","year":"2008","unstructured":"Sucharov C, Bristow MR, Port JD (2008) miRNA expression in the failing human heart: functional correlates. J Mol Cell Cardiol 45:185\u2013192","journal-title":"J Mol Cell Cardiol"},{"key":"300_CR31","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/j.ijcard.2016.12.171","volume":"230","author":"Q Zhou","year":"2017","unstructured":"Zhou Q, Sch\u00f6tterl S, Backes D, Brunner E, Hahn JK, Ionesi E et al (2017) Inhibition of miR-208b improves cardiac function in titin-based dilated cardiomyopathy. Int J Cardiol 230:634\u2013641","journal-title":"Int J Cardiol"},{"key":"300_CR32","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3389\/fphar.2019.00914","volume":"10","author":"L Shen","year":"2019","unstructured":"Shen L, Li C, Zhang H, Qiu S, Fu T, Xu Y (2019) Downregulation of miR-146a contributes to cardiac dysfunction induced by the tyrosine kinase inhibitor sunitinib. Front in Pharmacol 10:10\u201313","journal-title":"Front in Pharmacol"},{"key":"300_CR33","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1002\/lt.23377","volume":"18","author":"CJ Steer","year":"2012","unstructured":"Steer CJ, Subramanian S (2012) Circulating microRNAs as biomarkers: a new frontier in diagnostics. Liver Transpl 18:265\u2013269","journal-title":"Liver Transpl"},{"key":"300_CR34","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1038\/ejhg.2012.173","volume":"21","author":"T Meyer","year":"2013","unstructured":"Meyer T, Ruppert V, Ackermann S et al (2013) Novel mutations in the sarcomeric protein myopalladin in patients with dilated cardiomyopathy. Eur J Hum Genet 21:294\u2013300","journal-title":"Eur J Hum Genet"},{"key":"300_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4172\/2168-9784.1000e115","volume":"07","author":"J Takahashi","year":"2018","unstructured":"Takahashi J, Iwahashi H (2018) For novel disease diagnostic markers in Blood RNA. J Med Diagn Methods 07:1\u20133","journal-title":"J Med Diagn Methods"},{"key":"300_CR36","doi-asserted-by":"publisher","first-page":"e79792","DOI":"10.1371\/journal.pone.0079792","volume":"8","author":"MM Molina-Navarro","year":"2013","unstructured":"Molina-Navarro MM, Rosell\u00f3-Llet\u00ed E, Ortega A, Taraz\u00f3n E, Otero M, Mart\u00ednez-Dolz L et al (2013) Differential gene expression of cardiac ion channels in human dilated cardiomyopathy. PLoS ONE 8:e79792","journal-title":"PLoS ONE"},{"key":"300_CR37","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3389\/fped.2019.00387","volume":"7","author":"Q Guo","year":"2019","unstructured":"Guo Q, Liu J, Zhu P, Liu Y, Dong N, Shi J et al (2019) Evaluation of drug-related receptors in children with dilated cardiomyopathy. Front Pediatr 7:20\u201323","journal-title":"Front Pediatr"},{"key":"300_CR38","doi-asserted-by":"publisher","first-page":"jcs210443","DOI":"10.1242\/jcs.210443","volume":"131","author":"PJ Stanczyk","year":"2018","unstructured":"Stanczyk PJ, Seidel M, White J, Viero C, George CH, Zissimopoulos S et al (2018) Association of cardiac myosin-binding protein-C with the ryanodine receptor channel\u2013putative retrograde regulation? J Cell Sci 131:jcs210443","journal-title":"J Cell Sci"},{"issue":"8","key":"300_CR39","doi-asserted-by":"publisher","first-page":"13680","DOI":"10.1002\/jcb.28641","volume":"120","author":"Y Li","year":"2019","unstructured":"Li Y, Li Q, Zhang O, Guan X, Xue Y, Li S et al (2019) miR-202-5p protects rat against myocardial ischemia reperfusion injury by downregulating the expression of Trpv2 to attenuate the Ca2+ overload in cardiomyocytes. J Cell Biochem 120(8):13680\u201313693","journal-title":"J Cell Biochem"},{"issue":"6","key":"300_CR40","doi-asserted-by":"publisher","first-page":"e28324","DOI":"10.1371\/journal.pone.0028324","volume":"2011","author":"AE Belevych","year":"2011","unstructured":"Belevych AE, Sansom SE, Terentyeva R, Ho HT, Nishijima Y, Martin MM et al (2011) MicroRNA-1 and -133 increase arrhythmogenesis in heart failure by dissociating phosphatase activity from RyR2 complex. PLoS ONE 2011(6):e28324","journal-title":"PLoS ONE"},{"key":"300_CR41","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s11010-011-1136-3","volume":"362","author":"HF Xu","year":"2012","unstructured":"Xu HF, Ding YJ, Shen YW, Xue AM, Xu HM, Luo CL et al (2012) MicroRNA-1 represses Cx43 expression in viral myocarditis. Mol Cell Biochem 362:141\u2013148","journal-title":"Mol Cell Biochem"},{"key":"300_CR42","doi-asserted-by":"publisher","first-page":"e70158","DOI":"10.1371\/journal.pone.0070158","volume":"8","author":"A Curcio","year":"2013","unstructured":"Curcio A, Torella D, Iaconetti C, Pasceri E, Sabatino J, Sorrentino S et al (2013) MicroRNA-1 downregulation increases connexin 43 displacement and induces ventricular tachyarrhythmias in rodent hypertrophic hearts. PLoS ONE 8:e70158","journal-title":"PLoS ONE"},{"key":"300_CR43","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1039\/C5MB00806A","volume":"12","author":"C Liao","year":"2016","unstructured":"Liao C, Gui Y, Guo Y, Xu D (2016) The regulatory function of microRNA-1 in arrhythmias. Mol Biosyst 12:328\u2013333","journal-title":"Mol Biosyst"},{"issue":"7","key":"300_CR44","doi-asserted-by":"publisher","first-page":"e023472","DOI":"10.1161\/JAHA.121.023472","volume":"11","author":"F Wiedmann","year":"2022","unstructured":"Wiedmann F, Kraft M, Kallenberger S, B\u00fcscher A, Paasche A, Blochberger PL et al (2022) MicroRNAs regulate TASK-1 and are linked to myocardial dilatation in atrial fibrillation. J Am Heart Assoc 11(7):e023472","journal-title":"J Am Heart Assoc"},{"key":"300_CR45","first-page":"547","volume":"72","author":"HS Feng","year":"1992","unstructured":"Feng HS (1992) Correlation of intra-erythrocytic Na, K, Ca, Mg contents and ATPase activity with dilated cardiomyopathy. Chung Hua I Hsueh Tsa Chih Taipei 72:547\u2013549","journal-title":"Chung Hua I Hsueh Tsa Chih Taipei"},{"key":"300_CR46","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1152\/ajpheart.00425.2002","volume":"285","author":"DM Plank","year":"2003","unstructured":"Plank DM, Yatani A, Ritsu H, Witt S, Glascock B, Lalli MJ et al (2003) Calcium dynamics in the failing heart: restoration by \u03b2-adrenergic receptor blockade. Am J Physiol-Heart Circ Physiol 285:305\u2013315","journal-title":"Am J Physiol-Heart Circ Physiol"},{"key":"300_CR47","first-page":"1","volume":"11","author":"I El-Battrawy","year":"2018","unstructured":"El-Battrawy I, Zhao Z, Lan H, Li X, Y\u00fccel G, Lang S et al (2018) Ion channel dysfunctions in dilated cardiomyopathy in Limb-Girdle muscular dystrophy. Circ Genomic Preci Med 11:1\u20133","journal-title":"Circ Genomic Preci Med"},{"key":"300_CR48","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1096\/fj.201801057R","volume":"33","author":"AR Ednie","year":"2018","unstructured":"Ednie AR, Deng W, Yip K-P, Bennett ES (2018) Reduced myocyte complex N-glycosylation causes dilated cardiomyopathy. FASEB J 33:1248\u20131261","journal-title":"FASEB J"}],"container-title":["The Egyptian Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43044-022-00300-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s43044-022-00300-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43044-022-00300-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,18]],"date-time":"2022-11-18T23:08:56Z","timestamp":1668812936000},"score":1,"resource":{"primary":{"URL":"https:\/\/tehj.springeropen.com\/articles\/10.1186\/s43044-022-00300-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,8]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["300"],"URL":"https:\/\/doi.org\/10.1186\/s43044-022-00300-x","relation":{},"ISSN":["2090-911X"],"issn-type":[{"value":"2090-911X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,8]]},"assertion":[{"value":"23 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The agreement signature on the consent form the children\u2019s parents or guardians was taken. The study protocol was ethically approved by medical research ethics committee (MREC) at national research centre (NRC) under decision no. 20177.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"65"}}